Zydus Lifesciences Limited — Strip Exporter Profile
Indian Pharmaceutical Exporter · #9 for Strip · $1.3M export value · DGFT Verified
Zydus Lifesciences Limited is the #9 Indian exporter of Strip with $1.3M in export value and 46 verified shipments. Zydus Lifesciences Limited holds a 0.6% market share in Strip exports across 5 countries. The company exports 81 pharmaceutical products worth $346.3M across 25 therapeutic categories.
Zydus Lifesciences Limited — Strip Export Profile: Buyers & Destinations
Where Does Zydus Lifesciences Limited Export Strip?
| Country | Value | Shipments | Share |
|---|---|---|---|
| VIETNAM, DEMOCRATIC REP. OF | $836.2K | 35 | 75.6% |
| THAILAND | $252.0K | 6 | 22.8% |
| MAURITIUS | $15.0K | 1 | 1.4% |
| BHUTAN | $3.2K | 1 | 0.3% |
| BRAZIL | $7 | 3 | 0.0% |
Zydus Lifesciences Limited exports Strip to 5 countries. The largest destination is VIETNAM, DEMOCRATIC REP. OF accounting for 75.6% of Zydus Lifesciences Limited's Strip shipments, followed by THAILAND (22.8%) and MAURITIUS (1.4%). These destinations reflect Zydus Lifesciences Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Strip from Zydus Lifesciences Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| HAPHARCO J.S.C. BRANCH | VIETNAM, DEMOCRATIC REP. OF | $836.2K | 35 |
| PHARMALAND (1982) CO. LTD | THAILAND | $152.0K | 4 |
| PHARMALAND (1982) CO.LTD | THAILAND | $50.0K | 1 |
| PHARMALAND 1982 CO LTD | THAILAND | $50.0K | 1 |
| FTM MAURITIUS LTD | MAURITIUS | $15.0K | 1 |
| LAMGONG PHARMACEUTICALS & MEDICAL | BHUTAN | $3.2K | 1 |
| ZYDUS NIKKHO FARMACEUTICA LTDA | BRAZIL | $7 | 3 |
Zydus Lifesciences Limited supplies Strip to 7 buyers globally. The largest buyer is HAPHARCO J.S.C. BRANCH (VIETNAM, DEMOCRATIC REP. OF), followed by PHARMALAND (1982) CO. LTD (THAILAND) and PHARMALAND (1982) CO.LTD (THAILAND). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Strip Export Value and How Much Does Zydus Lifesciences Limited Contribute?
India exported $140.4M worth of Strip through 15,000 shipments from 612 suppliers to 170 countries, serving 2,109 buyers globally. Zydus Lifesciences Limited contributes $1.3M to this total, accounting for 0.6% of India's Strip exports. Zydus Lifesciences Limited ships Strip to 5 countries through 7 buyers.
What Is the Average Shipment Value for Zydus Lifesciences Limited's Strip Exports?
Zydus Lifesciences Limited's average Strip shipment value is $27.2K per consignment, based on 46 shipments totaling $1.3M. The largest destination is VIETNAM, DEMOCRATIC REP. OF (75.6% of Zydus Lifesciences Limited's Strip exports).
How Does Zydus Lifesciences Limited Compare to Other Indian Strip Exporters?
Zydus Lifesciences Limited ranks #9 among 612 Indian Strip exporters with a 0.6% market share. The top 3 exporters are SUN PHARMACEUTICAL INDUSTRIES LIMITED ($119.8M), SUN PHARMACEUTICAL INDUSTRIES LTD ($5.8M), SRS PHARMACEUTICALS PRIVATE LIMITED ($2.7M). Zydus Lifesciences Limited processed 46 shipments to 5 destination countries.
What Strip Formulations Does Zydus Lifesciences Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| OCID 20MG CAPSULE- STRIP(OMEPRAZOLE)(10X10) | $283.2K | 16 |
| OCID 20MG CAPSULE- STRIP (OMEPRAZOLE) 10 | $189.2K | 5 |
| OCID 20MG CAPSULE-STRIP (OMEPRAZOLE) 10X | $117.7K | 4 |
| OCID (OMEPRAZOLE 20MG CAPSULE STRIP) 10X | $50.0K | 1 |
| OCID (OMEPRAZOLE 20MG CAPSULE-STRIP) 10 | $50.0K | 1 |
| OCID(OMEPRAZOLE 20MG CAPSULE- STRIP) 10X | $50.0K | 1 |
| OCID OMEPRAZOLE 20MG CAPSULE STRIP B No G300272 G300273 MFG DT 02 2023 EXP DT 01 2026 | $50.0K | 1 |
| OCID (OMEPRAZOLE 20MG CAPSULE- STRIP) (P | $50.0K | 1 |
| OCID 20MG CAPSULE- STRIP (OMEPRAZOLE)(10 | $50.0K | 1 |
| OCID 20MG CAPSULE -STRIP(OMEPRAZOLE)(10X | $48.5K | 1 |
Zydus Lifesciences Limited exports 20 distinct Strip formulations including tablets, capsules, syrups, and combination drugs. The top formulation is OCID 20MG CAPSULE- STRIP(OMEPRAZOLE)(10X10) with 16 shipments worth $283.2K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Zydus Lifesciences Limited Compare to Nearest Strip Exporters?
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | MANEESH PHARMACEUTICALS LIMITED | $1.7M | 34 | 6 | $50.0K |
| 3 | AP WAREHOUSING AND TRADING LLP | $1.4M | 28 | 1 | $50.0K |
| 9 | ZYDUS LIFESCIENCES LIMITED ★ | $1.3M | 46 | 5 | $27.2K |
| 10 | MDC EXPORTS PRIVATE LIMITED | $897.8K | 71 | 1 | $12.6K |
| 11 | AVANTIKA MEDEX PRIVATE LIMITED | $800.0K | 16 | 2 | $50.0K |
Zydus Lifesciences Limited ranks #9 among 612 Indian Strip exporters. Average shipment value of $27.2K compared to the market average of $229.4K. The closest competitors by value are MANEESH PHARMACEUTICALS LIMITED and AP WAREHOUSING AND TRADING LLP.
Which Indian Ports Ship Strip Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 3,252 | 21.7% |
| SAHAR AIR | 2,848 | 19.0% |
| Bombay Air Cargo | 714 | 4.8% |
| NHAVA SHEVA SEA (INNSA1) | 701 | 4.7% |
| DELHI AIR | 672 | 4.5% |
| DHANNAD ICD | 615 | 4.1% |
| Bombay Air | 577 | 3.8% |
| DELHI AIR CARGO ACC (INDEL4) | 483 | 3.2% |
Geopolitical & Trade Policy Impact on Zydus Lifesciences Limited's Strip Exports
Zydus Lifesciences's export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic logistics planning to mitigate potential delays and cost escalations.
Conversely, U.S.-China trade tensions have opened opportunities for Indian pharmaceutical companies like Zydus to capture a larger share of the U.S. market, as American importers seek alternative suppliers. Zydus's recent FDA approvals, including Niacin ER Tablets and Leuprolide Acetate injection, position the company to capitalize on this shift. (ainvest.com)
In the European Union, compliance with the Falsified Medicines Directive (FMD) is crucial for market access. Zydus's proactive measures to align with these regulations enhance its credibility and competitiveness in the EU market. However, the ongoing Israel-Iran conflict poses risks to Middle East trade routes, potentially affecting Zydus's operations in that region.
Zydus Lifesciences Limited — Regulatory Compliance & Quality Standards
Maintaining stringent quality standards is paramount for Zydus Lifesciences. In October 2025, the company received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the U.S. FDA for its Baddi manufacturing facility, indicating compliance with regulatory standards. (bajajbroking.in) Similarly, the Ahmedabad SEZ-II facility received a clean USFDA report in November 2025, further affirming the company's commitment to quality. (bajajbroking.in)
These regulatory approvals are critical, as non-compliance can lead to import bans and reputational damage. Zydus's adherence to Good Manufacturing Practices (GMP) and proactive engagement with regulatory bodies underscore its dedication to maintaining high-quality standards across its operations.
About Zydus Lifesciences Limited
Zydus Lifesciences Limited exports 81 products worth $346.3M. Beyond Strip, top products include Losartan, Carvedilol, Iron, Mesalamine, Omeprazole. View the complete Zydus Lifesciences Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Strip — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Strip shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Zydus Lifesciences Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 46 individual customs records matching Zydus Lifesciences Limited exporting Strip, covering 20 formulations to 5 countries via 7 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 170+ countries, 2,109+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Strip Export Data from Zydus Lifesciences Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Zydus Lifesciences Limited's Strip exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Zydus Lifesciences Limited
Full Company Profile →
81 products · $346.3M total trade · 25 categories
Strip Stats
Company Overview
Top Products by Zydus Lifesciences Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Zydus Lifesciences Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Strip. For current shipment-level data, contact TransData Nexus.